Innate Pharma SA Class A (EURONEXT:IPH) - Share price - Overview

Stock Report

Innate Pharma SA IPH

Last Price
6.39

Day Change
-0.16|-2.44%

As of 20/02/2019
17:35:03 CET | EUR
Minimum 15 Minutes Delay.

Last Close6.55
Day Range6.35 - 6.62
Mkt Cap418.60Mil
52-Wk Range4.41 - 9.00
Yield %-
ISINFR0010331421
Volume152,945
P/E-8.64
P/S10.83
P/CF-6.09

Share Price

Financials
201520162017
More ...
Income Statement
Revenue17.9156.1632.63
Operating Income-10.777.57-39.98
Net Income-6.7112.64-48.39
Basic EPS-0.130.23-0.89
Avg. Diluted Shares Outstanding535454
Balance Sheet
Current Assets252.13230.08137.52
Non Current Assets53.8351.50117.50
Total Assets305.96281.58255.02
Current Liabilities60.1676.4473.91
Total Liabilities233.89195.41169.07
Total Equity72.0786.1785.96
Cash Flow
Operating Cash Flow207.91-36.85-48.06
Capital Expenditure-7.40-9.39-6.03
Free Cash Flow200.52-46.24-54.09

In millions, except "Basic EPS". Currency is EUR.

Company Profile

Innate Pharma SA is a clinical-stage biotechnology company. The company is engaged in developing immunotherapy drugs for cancer and inflammatory diseases.

Sector

Healthcare

Industry

Biotechnology

Stock Style

Small-Growth

Fiscal Year Ends

December

Employees

194
Key Stats
More ...
Price/Earning TTM-8.85
Price/Book4.80
Price/Sales TTM10.84
Rev Growth (3 year avg)230.12
EPS Growth (3 year avg)-
Operating Margin % TTM-122.52
Net Margin % TTM-148.28
ROE TTM-56.22
Debt/Equity0.05
Dividends
PreviousLatest
More ...
Declared Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2019 Morningstar. All rights reserved.